133 related articles for article (PubMed ID: 1735432)
1. Photoaffinity labelling of cholinesterases. Discrimination between active and peripheral sites.
Ehret-Sabatier L; Schalk I; Goeldner M; Hirth C
Eur J Biochem; 1992 Feb; 203(3):475-81. PubMed ID: 1735432
[TBL] [Abstract][Full Text] [Related]
2. p-Butyroxybenzenediazonium fluoroborate, substrate of acetylcholinesterase and butyrylcholinesterase, discriminates between the two enzymes by a specific affinity labelling.
Ehret-Sabatier L; Goeldner MP; Hirth CG
Biochim Biophys Acta; 1991 Jan; 1076(1):137-42. PubMed ID: 1986786
[TBL] [Abstract][Full Text] [Related]
3. Trp279 is involved in the binding of quaternary ammonium at the peripheral site of Torpedo marmorata acetylcholinesterase.
Schalk I; Ehret-Sabatier L; Bouet F; Goeldner M; Hirth C
Eur J Biochem; 1994 Jan; 219(1-2):155-9. PubMed ID: 8306982
[TBL] [Abstract][Full Text] [Related]
4. Cage amines as the stopper inhibitors of cholinesterases.
Lin G; Tsai HJ; Tsai YH
Bioorg Med Chem Lett; 2003 Sep; 13(17):2887-90. PubMed ID: 14611850
[TBL] [Abstract][Full Text] [Related]
5. 6-Coumarin diazonium salt: a specific affinity label of the Torpedo acetylcholinesterase peripheral site.
Schalk I; Ehret-Sabatier L; Le Feuvre Y; Bon S; Massoulie J; Goeldner M
Mol Pharmacol; 1995 Dec; 48(6):1063-7. PubMed ID: 8848006
[TBL] [Abstract][Full Text] [Related]
6. Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates.
Chiou SY; Huang CF; Hwang MT; Lin G
J Biochem Mol Toxicol; 2009; 23(5):303-8. PubMed ID: 19827033
[TBL] [Abstract][Full Text] [Related]
7. Biochemical evaluation of photolabile precursors of choline and of carbamylcholine for potential time-resolved crystallographic studies on cholinesterases.
Peng L; Silman I; Sussman J; Goeldner M
Biochemistry; 1996 Aug; 35(33):10854-61. PubMed ID: 8718877
[TBL] [Abstract][Full Text] [Related]
8. [Ligands of cholinesterases of ephedrine and pseudoephedrine structure].
Basova NE; Kormilitsin BN; Perchenok AY; Rozengatt EV; Saakov VS; Suvorov AA
Zh Evol Biokhim Fiziol; 2013; 49(6):385-93. PubMed ID: 25490843
[TBL] [Abstract][Full Text] [Related]
9. Specific photoaffinity labeling induced by energy transfer: application to irreversible inhibition of acetylcholinesterase.
Goeldner MP; Hirth CG
Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6439-42. PubMed ID: 6935657
[TBL] [Abstract][Full Text] [Related]
10. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
11. [Design, synthesis and evaluation of bis-nicotine derivatives as inhibitors of cholinesterases and beta-amyloid aggregation].
Luo W; Zhao YM; Tian RG; Su YB; Hong C
Yao Xue Xue Bao; 2013 Nov; 48(11):1671-6. PubMed ID: 24475704
[TBL] [Abstract][Full Text] [Related]
12. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
13. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.
Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056
[TBL] [Abstract][Full Text] [Related]
15. Selective labeling of anionic binding sites of the acetylcholinesterase from Torpedo californica with a photoaffinity label.
Layer P; Kiefer HR; Hucho F
Mol Pharmacol; 1976 Nov; 12(6):958-65. PubMed ID: 1004492
[No Abstract] [Full Text] [Related]
16. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
[TBL] [Abstract][Full Text] [Related]
17. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.
Harel M; Schalk I; Ehret-Sabatier L; Bouet F; Goeldner M; Hirth C; Axelsen PH; Silman I; Sussman JL
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9031-5. PubMed ID: 8415649
[TBL] [Abstract][Full Text] [Related]
18. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
[TBL] [Abstract][Full Text] [Related]
19. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A
J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436
[TBL] [Abstract][Full Text] [Related]
20. The mechanism and benefit of human butyrylcholinesterase activation by what would otherwise be inhibitors.
Stojan J
Chem Biol Interact; 2019 Aug; 308():350-356. PubMed ID: 31173753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
